Options for prevention of HIV transmission from mother to child, with a focus on developing countries

Pediatric Drugs

Volumn 4, Issue 3, 2002, Pages 191-203

  Kuhn, Louise ^a,b   Peterson, Ingrid ^a,b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Joseph L Mailman School of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; ZIDOVUDINE;

ANTISEPSIS; BREAST FEEDING; CESAREAN SECTION; CHILD CARE; CLINICAL TRIAL; DEVELOPING COUNTRY; DIARRHEA; DISEASE ASSOCIATION; DRUG COST; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MATERNAL CARE; MORTALITY; NEWBORN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SOUTH AFRICA; SUPPLEMENTATION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; BREAST FEEDING; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; PREGNANCY; RANDOMIZED CONTROLLED TRIALS;

EID: 0036214104     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200204030-00006     Document Type: Review

References (118)

1. Mother-to-infant HIV transmission: Timing, risk factors and prevention
2. Can perinatal HIV infection be eliminated in the United States?
3. Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice
4. Mechanisms and timing of mother-to-child transmission of HIV-1
5. Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children
6. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission
7. Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method
8. Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture
9. Sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period
10. Proposed definitions for in utero versus intrapartum transmission of HIV-1
11. High risk of HIV-1 infection for first-born twins
12. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins
13. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus
14. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: A meta-analysis of 15 prospective cohort studies
15. A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus
16. HIV-1 proviral DNA polymerase chain reaction detection in chorionic villi after exclusion of maternal contamination by variable number of tandem repeats analysis
17. Selection of maternal human immunodeficiency virus type 1 variants in human placenta
18. Human immunodeficiency virus type 1 infection of human placenta: Potential route for fetal infection
19. Human immunodeficiency virus type 1 infection of human placental macrophages in vitro
20. The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy
21. Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester
22. Frequent and early in utero HIV-1 infection
23. Maternofetal transmission of AIDS: Frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA
24. Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection
25. Risk of human immunodeficiency virus type 1 transmission through breastfeeding
26. Effect of breastfeeding and formula feeding on transmission of HIV-1: A randomized clinical trial
27. HIV transmission through breast feeding: A study in Malawi
28. Mother-to-child transmission of HIV: Implications of variation in maternal infectivity
29. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire
30. HIV-1 seroconversion after 20 months of age in a cohort of breastfed children born to HIV-1 infected women in Rwanda
31. Transient seroreversion in children born to human immunodeficiency virus 1-infected mothers
32. Mother-to-child transmission of human immunodeficiency virus type 1: Report from the Nairobi study
33. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire
34. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection
35. Effects of age of introduction of complementary foods on infant breast milk intake, total energy intake, and growth: A randomised intervention study in Honduras
36. Infant-feeding practices and their relationship with diarrheal and other diseases in Huascar (Lima) Peru
37. Incidence and etiology of infantile diarrhea and major routes of transmission in Huascar, Peru
38. Impact of breast feeding on admission for pneumonia during the postnatal period in Brazil: Nested case-control study
39. Influence of infant feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa
40. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda
41. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
42. After AIDS clinical trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants
43. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery
44. Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1
45. Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1
46. Impact of zidovudine use on risk and risk factors for perinatal transmission of human immunodeficiency virus
47. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
48. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties
49. Trends in perinatal transmission of HIV/AIDS in the United States
50. Using HIV/AIDS surveillance to monitor public health efforts to reduce perinatal transmission of HIV
51. Success in implementing public health service guidelines to reduce perinatal transmission of HIV - Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996
52. The debate over maternal-fetal HIV transmission prevention trials in Africa, Asia, and the Caribbean: Racist exploitation or exploitation of racism?
53. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: A randomized trial
54. 6-Month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breast fed children in Côte d'Ivoire and Burkina Faso: A double-blind placebo-controlled multicentre trial
55. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomized controlled trial
56. Results of the PETRA intervention trial to prevent perinatal transmission in sub-Saharan Africa
57. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
58. 15-Month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children
59. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1
60. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant
61. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
62. The effect of maternal viral load on the risk of perinatal transmission of HIV-1
63. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
64. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood: France, United Kingdom, and United States, January 1988-August 1994
65. Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women
66. Trends in antiretroviral therapy and mother-infant transmission of HIV
67. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 study
68. Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok
69. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
70. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1
71. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: Absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts
72. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero
73. Selective vertical transmission of HIV-1 antiretroviral resistance mutations
74. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in Pediatric AIDS Clinical Trial Group Protocol 076
75. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1
76. HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the women and infants transmission study
77. Codon 215 mutations in human immunodeficiency virus-infected pregnant women
78. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
79. Caesarean section and risk of vertical transmission of HIV-1 infection
80. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohorts
81. Elective caesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial
82. Prevention of vertical HIV transmission: Additive protective effect of elective cesarean section and zidovudine prophylaxis
83. Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission
84. Randomised trial testing effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child transmission of HIV-1 in Durban, South Africa
85. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania
86. Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: Clinical trial in Mombassa, Kenya
87. The incidence of complications after caesarean section in 156 HIV-positive women
88. Post-cesarean section morbidity in HIV-positive women
89. Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labor
90. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: Clinical trial
91. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1
92. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users
93. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women
94. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania
95. Infant feeding policy and practice in the presence of HIV-1 infection
96. Mother's milk and sewage: Their interactive effects on infant mortality
97. Breast feeding, nutritional state, and child survival in rural Bangladesh
98. Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil
99. Infant feeding and infant mortality in rural Chile
100. Does breastfeeding really save lives, or are apparent benefits due to biases?
101. Interventions for the control of diarrhoeal diseases among young children: Promotion of breast-feeding
102. HIV and infant feeding practices: Epidemiological implications for sub-Saharan African countries
103. Modeling the impact of breast-feeding by HIV-infected women on child survival
104. HIV infection and breast-feeding: Policy implications through a decision analysis model
105. Estimating infant mortality from human immunodeficiency virus and other causes in breast-feeding and bottle-feeding populations
106. HIV, breast-feeding and under-5 mortality: Modelling the impact of policy decisions for or against breast-feeding
107. Infant survival, HIV infection and feeding alternatives in less developed countries
108. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: Prospective cohort study from Durban, South Africa
109. Exclusive breast-feeding: Does it have the potential to reduce breast-feeding transmission of HIV-1?
110. Breast-feeding and health in the 1980s: A global epidemiologic review
111. Breast milk or animal-product foods improve linear growth of Peruvian toddlers consuming marginal diets
112. Lactation amenorrhea
113. Effect of breastfeeding on mortality among HIV-1 infected women: A randomised trial
114. Are HIV-infected women who breastfeed at increased risk of mortality?
115. Efficacy of home-based peer counselling to promote exclusive breastfeeding: A randomised controlled trial
116. Effect of community-based peer counsellors on exclusive breastfeeding practices in Dhaka, Bangladesh: A randomised controlled trial
117. Promotion of Breastfeeding Intervention Trial (PROBIT): A randomized trial in the Republic of Belarus